CorTechs Labs’ flagship product, NeuroQuant®, is the first FDA 510(k) cleared, CE marked and Health Canada licensed medical device software that makes quantitative analysis of MRI images of the human brain a routine part of clinical practice. NeuroQuant brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician’s desktop or mobile device. It provides physicians with a sophisticated tool to measure brain structure volumes, confidently assess the presence of neurodegeneration of brain structures and ultimately improve patient care – all within minutes.
LesionQuant™, a NeuroQuant product, launched in August 2016, takes clinical treatment planning and disease progression monitoring to the next level. By combining FLAIR and 3D T1 image analysis, LesionQuant provides clinicians with FLAIR lesion and subcortical brain structure quantification, as well as, lesion and lesion change visualization aids. Powered by NeuroQuant and Dynamic Atlas™ technology, LesionQuant is ready for clinical and research needs, delivers significant time savings with automated image analysis, and is available for a broad age range of 3 to 100 years.
In March 2016, we launched our research product, PETQuant™, enabling physicians and researchers to perform post-acquisition analyses of PET brain studies to quantify subregional tracer binding in native patient brain space. The PET tracer binding is accurately localized to identified brain structures via a paired NeuroQuant compatible T1-weighted MRI. PETQuant provides an additional tool in the evaluation of neurodegenerative dementias, such as Alzheimer’s disease and frontotemporal dementia. PETQuant is currently available for research use only.